dcSSccytokine release syndrome (CRS)diffuse cutaneous systemic sclerosis (dcSSc)CRStocilizumabeculizumabATGDutch university hospitalsAmerican Society for Transplantation and Cellular Therapy
…the median disease duration was 13 months (IQR 7-23). 87.1% had dcSSc and 12.9% had limited cutaneous SSc. At baseline the mean perce…